A LEGAL ANALYSIS OF XENOTRANSPLANTATION IN MALAYSIA


Date Published : 15 December 2025

Contributors

Farah Salwani Muda@Ismail

Author

Keywords

Xenotransplantation Organ Shortage Laws

Proceeding

Track

Article

License

Copyright (c) 2025 Farah Salwani Muda@Ismail;

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Abstract

Xenotransplantation is the transplantation of living cells, tissues, or organs from animals to humans which has emerged as a potential solution to the persistent organ shortage in Malaysia. As demand for human organs continues to exceed supply, xenotransplantation offers a promising alternative to alleviate the critical gap and reduce mortality among patients awaiting transplantation. This study adopts a library research method, examining statutory materials, scholarly literature, and policy documents to assess the existing Malaysian legal framework relevant to xenotransplantation. The analysis highlights that although Malaysia has enacted laws such as the Animal Welfare Act 2015, which regulates ethical treatment of animals, and the Biosafety Act 2007, which governs genetically modified organisms, these laws only provide fragmented and indirect regulation. They do not comprehensively address the complex ethical, biosafety, medical, religious, and liability issues uniquely associated with xenotransplantation. The findings reveal a significant regulatory gap, particularly in areas such as source animal requirements, genetic modification controls, infection risk management, consent standards, clinical trial governance, and post-transplant monitoring. In view of these shortcomings, this study proposes the establishment of a dedicated Xenotransplantation Act to provide a holistic and specialised legal framework. Such legislation would ensure patient safety, uphold ethical standards, support scientific advancement, and align Malaysia with international best practices as xenotransplantation moves closer to clinical application

 

 

References

Animal Welfare Act 2015 (Act 772) (Malaysia).
Biosafety Act 2007 (Act 678) (Malaysia).
Boulet, J., Cunningham, J. W., & Mehra, M. R. (2022). Cardiac xenotransplantation: Challenges, evolution, and advances. JACC: Basic to Translational Science.
Cooper, D. K. C., Ekser, B., Burlak, C., Ezzelarab, M., Hara, H., Paris, L., Tector, A. J., Phelps, C., Azimzadeh, A. M., Ayares, D., Robson, S. C., & Pierson, R. N. III. (2012). Clinical lung xenotransplantation: What donor genetic modifications may be necessary? Xenotransplantation, 19, 144–158.
Cooper, D. K. C., Ekser, B., & Tector, A. J. (2015). A brief history of clinical xenotransplantation. International Journal of Surgery, 23(B), 205–210.
Ekser, B., Cooper, D. K. C., & Tector, A. J. (2015). The need for xenotransplantation as a source of organs and cells for clinical transplantation. International Journal of Surgery, 23, 199–204.
Human Tissues Act 1974 (Act 130) (Malaysia).
Kawai, T., Williams, W. W., Elias, N., Fishman, J. A., Crisalli, K., Longchamp, A., Rosales, I. A., & Riella, L. V. (2025). Xenotransplantation of a porcine kidney for end-stage kidney disease. New England Journal of Medicine, 392(7), 1933–1940.
Lin, X. F. (2024). Pathogen-free pigs for safer xenotransplantation: Advances and challenges in genetic engineering. International Journal of Molecular Zoology, 14(4), 244–254.
Malaysia Medical Council. (2006). Guidelines 006/2006.
Ministry of Health Malaysia. (2007). National Organ, Tissue and Cell Transplantation Policy.
Ministry of Health Malaysia. (2011). Policy and Procedures for Unrelated Living Organ Donation.
Ministry of Health Malaysia. (n.d.). National Transplant Centre. https://dermaorgan.gov.my/pendermaan-organ
Montgomery, R. A., Stern, J. M., Lonze, B. E., Tatapudi, V. S., Mangiola, M., Wu, M., Weldon, E., & Stewart, Z. A. (2022). Results of two cases of pig-to-human kidney xenotransplantation. New England Journal of Medicine, 386, 1889–1898. https://doi.org/10.1056/NEJMoa2120238
Mou, L., Chen, F., Dai, Y., Cai, Z., & Cooper, D. K. C. (2015). Potential alternative approaches to xenotransplantation. International Journal of Surgery, 23, 322–326.
Organ Procurement and Transplantation Network. (2018). National data. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/
Peic, C. (2022, June 8). World’s first: Doctors successfully transplant human liver in a machine. Medical News Today.
Public Health Service. (2022, June 23). Guideline on infectious disease issues in xenotransplantation.
Starzl, T. E., Fung, J., & Tzaki, A. (1993). Baboon-to-human liver transplantation. The Lancet, 341, 65–71.
U.S. Food & Drug Administration. (n.d.). Xenotransplantation. https://www.fda.gov/vaccines-blood-biologics/xenotransplantation
U.S. Food and Drug Administration, Center for Biologics Evaluation and Research. (2016, December 13). Source animal, product, preclinical, and clinical issues concerning the use of xenotransplantation products in humans.
Yiswaree, P. (2022, June 10). National Transplant Centre: Almost all organ donation pledges’ wishes cannot be fulfilled. Malay Mail.

Downloads

How to Cite

Farah Salwani Muda@Ismail, F. S. M. (2025). A LEGAL ANALYSIS OF XENOTRANSPLANTATION IN MALAYSIA. International Conference on Syariah, Law and Science (CFORSJ I-CONF) - CFORSJ Procedia, 3(1), 238-244. https://alnadwah.usim.edu.my/cforsjprocedia/paper/view/209